1. Home
  2. SANG vs ABOS Comparison

SANG vs ABOS Comparison

Compare SANG & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sangoma Technologies Corporation

SANG

Sangoma Technologies Corporation

N/A

Current Price

$4.72

Market Cap

151.1M

Sector

Technology

ML Signal

N/A

Logo Acumen Pharmaceuticals Inc.

ABOS

Acumen Pharmaceuticals Inc.

N/A

Current Price

$0.20

Market Cap

165.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SANG
ABOS
Founded
1984
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
151.1M
165.6M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
SANG
ABOS
Price
$4.72
$0.20
Analyst Decision
Hold
Analyst Count
0
6
Target Price
N/A
★ $1.00
AVG Volume (30 Days)
51.3K
★ 5.5M
Earning Date
11-05-2026
10-26-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$2.57
N/A
Revenue Next Year
$1.61
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.40
$0.19
52 Week High
$5.42
$3.60

Technical Indicators

Market Signals
Indicator
SANG
ABOS
Relative Strength Index (RSI) 56.59 21.56
Support Level $4.37 $0.19
Resistance Level $4.74 $2.77
Average True Range (ATR) 0.11 0.04
MACD -0.00 0.01
Stochastic Oscillator 62.50 4.35

Price Performance

Historical Comparison
SANG
ABOS

About SANG Sangoma Technologies Corporation

Sangoma Technologies Corp is a provider of hardware and software components that enable or enhance Internet Protocol Communications Systems for both telecom and datacom applications. It is engaged in the development, manufacturing, distribution, and support of voice and data connectivity components for software-based communication applications. Its product includes data and telecom boards for media and signal processing, as well as gateway appliances and software. The Company sells into two geographic location USA and Other countries. Key revenue is generated from USA.

About ABOS Acumen Pharmaceuticals Inc.

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers. The product pipelines include: ALTITUDE-AD; and INTERCEPT-AD.

Share on Social Networks: